510(k) · Cleared
ClearedNeuroBlate System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Monteris Medical, · GEX Powered Laser Surgical Instrument
Cleared on Nov 17, 2017 as substantially equivalent to K172881 (Monteris Medical,, 2017) after a 30-day review. Its family tree reaches back 13 generations to 1999. 2 of the 44 devices in its family, counting itself, have a Class I recall. 12 later devices descend from it.
- Decided
- Nov 17, 2017
- Review
- 30 days
- Class
- Class II
- Product code
- GEX
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 13 generations to K983831 (1999). 31 ancestors in all, the oldest K913475 (1991). 12 later devices descend from it, 2 citing it directly. 2 of the 44 devices in this family, counting this one, have a Class I recall.
- Root · 13 generations backK983831 VECTORVISION2Brainlab AG · 1999
- 9 generations between
- 3 generations backK170724 NeuroBlate SystemMonteris Medical, · 2017
- 2 generations backK171255 Monteris Medical NeuroBlate SystemMonteris Medical, Inc. · 2017 · Recalled (Class I)
- 1 generation backK172881 NeuroBlate SystemMonteris Medical, · 2017
- This deviceK173305 NeuroBlate SystemMonteris Medical, · 2017
- Descendant · cites it directly · 11 of its ownK182036 NeuroBlate SystemMonteris Medical, · 2018
- Descendant · cites it directly · 10 of its ownK193375 NeuroBlate SystemMonteris Medical, · 2020
- Descendant · 2 generations on · 9 of its ownK201056 NeuroBlate SystemMonteris Medical, Inc. · 2020
- Descendant · 2 generations on · 7 of its ownK222983 NeuroBlate Fusion-S Software V3.17Monteris Medical, · 2023
- Descendant · 3 generations on · 7 of its ownK211269 Visualase MRI-Guided Laser Ablation System (SW 3.4)Medtronic Navigation, Inc. · 2022 · Recalled
Show all 13 generations
- Root · 13 generations backK983831 VECTORVISION2Brainlab AG · 1999
- 12 generations backK014256 Kolibri Igs SystemsBrainlab AG · 2002
- 11 generations backK042721 Kolibri SpineBrainlab AG · 2005
- 10 generations backK062086 NavivisionBrainlab AG · 2006
- 9 generations backK081509 Monteris Medical Autolitt Laser ProbeMonteris Medical, · 2009
- 8 generations backK120561 Neuroblate SystemMonteris Medical, Inc. · 2013 · Recalled
- 7 generations backK131278 Monteris Medical Neuroblate SystemMonteris Medical, Inc. · 2013 · Recalled
- 6 generations backK141983 Neuroblate SystemMonteris Medical Corp. · 2014 · Recalled
- 5 generations backK143457 NeuroBlate SystemMonteris Medical, Inc. · 2015 · Recalled (Class I)
- 4 generations backK162762 NeuroBlate SystemMonteris Medical, Inc. · 2016
- 3 generations backK170724 NeuroBlate SystemMonteris Medical, · 2017
- 2 generations backK171255 Monteris Medical NeuroBlate SystemMonteris Medical, Inc. · 2017 · Recalled (Class I)
- 1 generation backK172881 NeuroBlate SystemMonteris Medical, · 2017
- This deviceK173305 NeuroBlate SystemMonteris Medical, · 2017
Showing 5 of 12 descendants. See all descendants
Descendants cleared per year
Class I recalls in this family
Most influential descendants
Showing 5 of 12 · See all- K182036NeuroBlate SystemMonteris Medical, · 2018 · cites it directly11descendants
- K193375NeuroBlate SystemMonteris Medical, · 2020 · cites it directly10descendants
- K201056NeuroBlate SystemMonteris Medical, Inc. · 2020 · 2 generations on9descendants
- K222983NeuroBlate Fusion-S Software V3.17Monteris Medical, · 2023 · 2 generations on7descendants
- K211269Visualase MRI-Guided Laser Ablation System (SW 3.4)Medtronic Navigation, Inc. · 2022 · 3 generations on7descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −13 | K983831 | VECTORVISION2 | Brainlab AG | 1999 | — |
| −12 | K014256 | Kolibri Igs Systems | Brainlab AG | 2002 | — |
| −11 | K042721 | Kolibri Spine | Brainlab AG | 2005 | — |
| −10 | K062086 | Navivision | Brainlab AG | 2006 | — |
| −9 | K081509 | Monteris Medical Autolitt Laser Probe | Monteris Medical, | 2009 | — |
| −8 | K120561 | Neuroblate System | Monteris Medical, Inc. | 2013 | 1 |
| −7 | K131278 | Monteris Medical Neuroblate System | Monteris Medical, Inc. | 2013 | 1 |
| −6 | K141983 | Neuroblate System | Monteris Medical Corp. | 2014 | 2 |
| −5 | K143457 | NeuroBlate System | Monteris Medical, Inc. | 2015 | Class I |
| −4 | K162762 | NeuroBlate System | Monteris Medical, Inc. | 2016 | — |
| −3 | K170724 | NeuroBlate System | Monteris Medical, | 2017 | — |
| −2 | K171255 | Monteris Medical NeuroBlate System | Monteris Medical, Inc. | 2017 | Class I |
| −1 | K172881 | NeuroBlate System | Monteris Medical, | 2017 | — |
| 0 (this device) | K173305 | NeuroBlate System | Monteris Medical, | 2017 | — |
| +1 | K182036 | NeuroBlate System | Monteris Medical, | 2018 | — |
| +1 | K193375 | NeuroBlate System | Monteris Medical, | 2020 | — |
| +2 | K201056 | NeuroBlate System | Monteris Medical, Inc. | 2020 | — |
| +2 | K222983 | NeuroBlate Fusion-S Software V3.17 | Monteris Medical, | 2023 | — |
| +3 | K211269 | Visualase MRI-Guided Laser Ablation System (SW 3.4) | Medtronic Navigation, Inc. | 2022 | 1 |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1991 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2003 | 1 | 0 |
| 2006 | 4 | 0 |
| 2007 | 1 | 0 |
| 2013 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2018 | 1 | 0 |
| 2020 | 2 | 0 |
| 2022 | 1 | 0 |
| 2023 | 2 | 0 |
| 2024 | 1 | 0 |
| 2025 | 2 | 0 |
| 2026 | 3 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GEX device
- #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K172881 | NeuroBlate System Cleared while this submission was under review Summary page 4…e Manufacturer: Monteris Medical Predicate Device Common Name: Monteris NeuroBlate™ System Predicate Device Premarket Notification # K172881 Predicate Device Regulation: 21 CFR 878.4810 Laser surgical inst… | 2017 |
What descends from it? (12)
See all 122 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (2 Class I)
No FDA recall names this device.
Relatives with a Class I recall
Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.
What does this lineage say?
- The line of descent spans 18 years and passes through 4 companies; a new generation was cleared every 1.1 years on median.
- 11 of the 31 ancestors have a recall of any class; 2 have a Class I recall.
- Of its descendants, K182036 (Monteris Medical,, 2018) has gone furthest, with 11 descendants of its own.
- 1 other device also cites its predicate K172881.
How does its category compare?
All GEX devicesGEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.
FDA decisions per year · GEX
83in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GEX
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GEX
3in 2024
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · GEX
2,720in 2025
MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 73 | 79 | 9 | 342 |
| 2008 | 107 | 86 | 2 | 232 |
| 2009 | 69 | 100 | 0 | 209 |
| 2010 | 50 | 96 | 4 | 1,711 |
| 2011 | 41 | 83 | 18 | 3,024 |
| 2012 | 45 | 118 | 5 | 2,000 |
| 2013 | 46 | 144 | 3 | 2,236 |
| 2014 | 61 | 147 | 6 | 2,036 |
| 2015 | 47 | 112 | 0 | 2,099 |
| 2016 | 51 | 114 | 1 | 2,585 |
| 2017 | 67 | 90 | 5 (1) | 2,977 |
| 2018 | 51 | 78 | 5 | 3,525 |
| 2019 | 41 | 88 | 6 | 2,709 |
| 2020 | 52 | 90 | 1 | 2,183 |
| 2021 | 53 | 123 | 0 | 3,465 |
| 2022 | 60 | 152 | 0 | 2,288 |
| 2023 | 52 | 87 | 6 | 2,337 |
| 2024 | 82 | 90 | 3 | 2,187 |
| 2025 | 83 | 90 | 0 | 2,720 |
| 2026 | 57 | 90 | 2 | — |
What is it indicated for?
The Monteris Medical NeuroBlate™ System is indicated for use to ablate, necrotize, or coagulate intracranial soft tissue, including brain structures, through interstitial irradiation or thermal therapy in medicine and surgery in the discipline of neurosurgery with 1064 nm lasers. The Monteris Medical NeuroBlate™ System is intended for planning and monitoring thermal therapies under MRI visualization. It provides MRI based trajectory planning assistance…
Read the full statement (123 words)
The Monteris Medical NeuroBlate™ System is indicated for use to ablate, necrotize, or coagulate intracranial soft tissue, including brain structures, through interstitial irradiation or thermal therapy in medicine and surgery in the discipline of neurosurgery with 1064 nm lasers.
The Monteris Medical NeuroBlate™ System is intended for planning and monitoring thermal therapies under MRI visualization. It provides MRI based trajectory planning assistance for the stereotaxic placement of MRI compatible (conditional) NeuroBlate™ Laser Delivery Probes. It also provides real time thermographic analysis of selected MRI images.
When interpreted by a trained physician, this System provides information that may be useful in the determination or assessment of thermal therapy. Patient management decisions should not be made solely on the basis of the NeuroBlate™ System analysis.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K173305 · printed Nov 6, 2026
Cite this page
510(k) Report. “K173305: NeuroBlate System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K173305
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026